Setoperone | CAS#86487-64-1 | radioligand

MedKoo Cat#: 461062 | Name: Setoperone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Setoperone is a sensitive radioligand. Commonly used in position emission tomography (PET) imaging.

Chemical Structure

Setoperone

CAS#86487-64-1

Theoretical Analysis

MedKoo Cat#: 461062

Name: Setoperone

CAS#: 86487-64-1

Chemical Formula: C21H24FN3O2S

Exact Mass: 401.1573

Molecular Weight: 401.50

Elemental Analysis: C, 62.82; H, 6.03; F, 4.73; N, 10.47; O, 7.97; S, 7.99

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Setoperone; R 52245; R-52245; R52245;

IUPAC/Chemical Name

6-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)-7-methyl-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one

InChi Key

RBGAHDDQSRBDOG-UHFFFAOYSA-N

InChi Code

InChI=1S/C21H24FN3O2S/c1-14-18(20(27)25-12-13-28-21(25)23-14)8-11-24-9-6-16(7-10-24)19(26)15-2-4-17(22)5-3-15/h2-5,16H,6-13H2,1H3

SMILES Code

O=C1C(CCN2CCC(C(C3=CC=C(F)C=C3)=O)CC2)=C(C)N=C4N1CCS4

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 401.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Beversdorf DQ, Nordgren RE, Bonab AA, Fischman AJ, Weise SB, Dougherty DD, Felopulos GJ, Zhou FC, Bauman ML. 5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults. J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):191-7. doi: 10.1176/appi.neuropsych.11080202. PubMed PMID: 22772667. 2: Blin J, Crouzel C. Blood-cerebrospinal fluid and blood-brain barriers imaged by 18F-labeled metabolites of 18F-setoperone studied in humans using positron emission tomography. J Neurochem. 1992 Jun;58(6):2303-10. PubMed PMID: 1573409. 3: Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Lévy D, Pillon B, Fournier D, Vidailhet M, Agid Y. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone. Brain. 1993 Jun;116 ( Pt 3):497-510. PubMed PMID: 8513389. 4: Gerretsen P, Graff-Guerrero A, Menon M, Pollock BG, Kapur S, Vasdev N, Houle S, Mamo D. Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [(18)F]setoperone PET study. Soc Neurosci. 2010;5(4):375-83. doi: 10.1080/17470911003589309. Epub 2010 Mar 1. PubMed PMID: 20198536. 5: Blin J, Sette G, Fiorelli M, Bletry O, Elghozi JL, Crouzel C, Baron JC. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. J Neurochem. 1990 May;54(5):1744-54. PubMed PMID: 2182776. 6: Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM, Wilson AA, Kennedy SH. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry. 1999 Jul;156(7):1029-34. PubMed PMID: 10401447. 7: Verhoeff NP, Meyer JH, Kecojevic A, Hussey D, Lewis R, Tauscher J, Zipursky RB, Kapur S. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia. Psychiatry Res. 2000 Oct 30;99(3):123-35. PubMed PMID: 11068194. 8: Maziere B, Crouzel C, Venet M, Stulzaft O, Sanz G, Ottaviani M, Sejourne C, Pascal O, Bisserbe JC. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. Int J Rad Appl Instrum B. 1988;15(4):463-8. PubMed PMID: 3255742. 9: Petit-Taboué MC, Landeau B, Barré L, Onfroy MC, Noël MH, Baron JC. Parametric PET imaging of 5HT2A receptor distribution with 18F-setoperone in the normal human neocortex. J Nucl Med. 1999 Jan;40(1):25-32. PubMed PMID: 9935052. 10: Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, DaSilva J, Wilson AA, Rafi-Tari S, Mayberg HS, Kennedy SH. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry. 2001 Jan;158(1):78-85. PubMed PMID: 11136637. 11: Ngan ET, Yatham LN, Ruth TJ, Liddle PF. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone. Am J Psychiatry. 2000 Jun;157(6):1016-8. PubMed PMID: 10831488. 12: Attar-Lévy D, Martinot JL, Blin J, Dao-Castellana MH, Crouzel C, Mazoyer B, Poirier MF, Bourdel MC, Aymard N, Syrota A, Féline A. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry. 1999 Jan 15;45(2):180-6. PubMed PMID: 9951565. 13: Blin J, Pappata S, Kiyosawa M, Crouzel C, Baron JC. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. Eur J Pharmacol. 1988 Feb 16;147(1):73-82. PubMed PMID: 3259509. 14: Kapur S, Jones C, DaSilva J, Wilson A, Houle S. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. Nucl Med Commun. 1997 May;18(5):395-9. PubMed PMID: 9194079. 15: Meyer JH, Cho R, Kennedy S, Kapur S. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET. Psychopharmacology (Berl). 1999 Jun;144(3):279-81. PubMed PMID: 10435395. 16: Lewis R, Kapur S, Jones C, DaSilva J, Brown GM, Wilson AA, Houle S, Zipursky RB. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. Am J Psychiatry. 1999 Jan;156(1):72-8. PubMed PMID: 9892300. 17: Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PA. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology (Berl). 1986;88(4):434-44. PubMed PMID: 3010361. 18: Strome EM, Clark CM, Zis AP, Doudet DJ. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: an in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry. 2005 May 1;57(9):1004-10. PubMed PMID: 15860341. 19: Yatham LN, Liddle PF, Dennie J, Shiah IS, Adam MJ, Lane CJ, Lam RW, Ruth TJ. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry. 1999 Aug;56(8):705-11. PubMed PMID: 10435604. 20: Meco G, Lestingi L, Buzzi MG, Petrini P, Pasqualoni V, Falaschi P, Marini S. Neuroendocrine effects of setoperone: a new neuroleptic drug. Int J Clin Pharmacol Res. 1986;6(6):465-8. PubMed PMID: 2879803.